Travere Therapeutics, Inc. (TVTX)
52.30
+1.81
(+3.58%)
USD |
NASDAQ |
Oct 20, 16:00
52.26
-0.04
(-0.08%)
After-Hours: 20:00
Travere Therapeutics Gross Profit (TTM) : 519.70M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 519.70M |
| March 31, 2026 | 455.43M |
| December 31, 2025 | 419.65M |
| September 30, 2025 | 370.79M |
| June 30, 2025 | 273.34M |
| March 31, 2025 | 216.14M |
| December 31, 2024 | 181.87M |
| September 30, 2024 | 150.38M |
| June 30, 2024 | 124.67M |
| March 31, 2024 | 126.77M |
| December 31, 2023 | 116.90M |
| September 30, 2023 | 107.43M |
| June 30, 2023 | 103.90M |
| March 31, 2023 | 104.11M |
| December 31, 2022 | 123.24M |
| September 30, 2022 | 152.37M |
| June 30, 2022 | 190.31M |
| March 31, 2022 | 192.65M |
| December 31, 2021 | 193.20M |
| September 30, 2021 | 187.86M |
| June 30, 2021 | 173.04M |
| March 31, 2021 | 168.34M |
| December 31, 2020 | 169.28M |
| September 30, 2020 | 165.99M |
| June 30, 2020 | 159.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 157.16M |
| December 31, 2019 | 150.24M |
| September 30, 2019 | 148.02M |
| June 30, 2019 | 145.12M |
| March 31, 2019 | 141.89M |
| December 31, 2018 | 140.54M |
| September 30, 2018 | 139.62M |
| June 30, 2018 | 139.47M |
| March 31, 2018 | 137.49M |
| December 31, 2017 | 133.65M |
| September 30, 2017 | 129.05M |
| June 30, 2017 | 122.53M |
| March 31, 2017 | 117.17M |
| December 31, 2016 | 112.90M |
| September 30, 2016 | 106.83M |
| June 30, 2016 | 102.17M |
| March 31, 2016 | 93.47M |
| December 31, 2015 | 84.43M |
| September 30, 2015 | 71.62M |
| June 30, 2015 | 54.31M |
| March 31, 2015 | 38.76M |
| December 31, 2014 | 23.34M |
| September 30, 2014 | 10.22M |
| June 30, 2014 | 3.391M |
| March 31, 2014 | -1.235M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| TG Therapeutics, Inc. | 658.60M |
| BioMarin Pharmaceutical, Inc. | 2.556B |
| Vertex Pharmaceuticals, Inc. | 10.94B |
| Viridian Therapeutics, Inc. | 70.26M |
| Krystal Biotech, Inc. | 411.03M |